Cargando...
Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
Immunotherapy has revolutionized the treatment of both hematological malignancies and solid tumors. The use of immunotherapy has improved outcome for patients with cancer across multiple tumor types, including lung, melanoma, ovarian, genitourinary, and more recently breast cancer with durable respo...
Guardado en:
| Publicado en: | Front Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7228136/ https://ncbi.nlm.nih.gov/pubmed/32457830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00570 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|